Chengda Biology: Plans to invest in industrial funds to focus on frontier areas of health such as smart hospitals_Oriental Fortune Network

　　Chengda Biology(688739) The evening of March 11announcementSaid that the company intends to participate in the establishment of venture capitalfundSuzhou Puyu Venture Capital Partnership (Limited Partnership). The fund’s main investment areas are new business models, new products and new technologies in medical technology and related peripheral industries. Frontier fields of life and health such as cell and gene therapy.

Also participating in the establishment of this industry fund are Suzhou Yucheng Venture Capital Partnership (Limited Partnership), Nanjing Weidu Honghu Venture Capital Partnership (Limited Partnership), Shanghai Hengfeng Investment Management Co., Ltd., and Shanghai Jiangying Investment Management Co., Ltd. The total fundraising scale of the fund does not exceed 500 million yuan, and the first phase of the fundraising amount is 125 million yuan.Chengda BiologyAs one of the limited partners (LP), it is planned to subscribe for a contribution of 50 million yuan, accounting for 40% of the total subscribed capital for the first phase of the fund.

　　Chengda BiologySaid that this investment in industrial funds will help the company to achieve industrial chain coordination and promote the realization of its overall strategic goals. At the same time, this investment relies on the investment management experience and risk control system of professional investment institutions, which is conducive to optimizing the investment structure, improving investment returns, and providing guarantee for the company’s healthy and sustainable development.

(Article source: ChinasecuritiesReport · China Securities Network)

Article source: China Securities Journal China Securities Network

Responsible editor: 3

Original title: Chengda Biology: Plans to invest in industrial funds to focus on frontier areas of health such as smart hospitals